Assignee
SENTI BIOSCIENCES INC
US·4 granted patents·34 pending applications·8 citations·filing 2017–2025
Top patents by PatentIndex Score
38 records- 0187US10993967B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2019·Granted May 4, 2021·5 cites·31 claims
- 0285US11419898B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2021·Granted Aug 23, 2022·2 cites·20 claims
- 0379US12005081B2Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2021·Granted Jun 11, 2024·1 cites·28 claims
- 0467US2024277766A1Armed chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0565US2022378842A1Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0665US2024415891A1Activation responsive promoters and uses thereofSENTI BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0765US2024277765A1Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0864US2023270789A1Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0962US2025032548A1Antigen-binding domains and methods of use thereofSENTI BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1062US2024058384A1Chimeric antigen receptors and methods of useSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1162US2025041345A1Multicistronic chimeric protein expression systemsSENTI BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1261US2024182910A1Drug-regulatable transcription factorsSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1360US2024082303A1Protein payload releaseSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1460US2024091358A1Secretable payload regulationSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1559US11446332B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2018·Granted Sep 20, 2022·0 cites·18 claims
- 1659US2023235051A1Inhibitory chimeric receptor architecturesSENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1759US2024141364A1Drug-regulatable transcriptional repressorsSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1858US2024226296A9Ert2 mutants and uses thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1958US2023272037A1Inhibitory chimeric receptor architecturesSENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2058US2024042027A1Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2158US2024173410A1Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2258US2024150433A1Ert2 mutants and uses thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2357US2023011052A1Method and compositions for regulated armoring of cellsSENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2457US2025011384A1Cytokine-immunoreceptor fusion proteins and uses thereofSENTI BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2557US2023372486A1Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2656US2023405144A1Inducible cell death systemsSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2755US2026022364A1Ert2 mutants, inducible cell death systems, and uses thereofSENTI BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2853US2019233844A1Spatiotemporal regulatorsSENTI BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2953US2019169634A1Genetic erasersSENTI BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 3053US2026083859A1Sustained transgene expression of modified ert2 peptide-suicide protein fusion polypeptidesSENTI BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3151US2025297276A1Macrophage-specific promoters and uses thereofSENTI BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3250US2022396609A1Chimeric receptor sensorsSENTI BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3349US2021189367A1Inducible Cell Receptors for Cell-Based TherapeuticsSENTI BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 3448US2022289842A1Chimeric inhibitory receptorSENTI BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3547US2022090040A1Fusion Constructs for Controlling Protein FunctionSENTI BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3646US2025339534A1Inhibitory chimeric receptor architecturesSENTI BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3744US2020085876A1Immunomodulating cell circuitsSENTI BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 3841US2025222133A1Cell-type specific regulatory elements for photoreceptorsSENTI BIOSCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SENTI BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →